Caraco news

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution

Par Pharmaceutical Companies Inc. Beats Analyst Expectations; PRX, CPD, HITK

GMP deviators keep paying

FiercePharma Manufacturing - 1 hour ago
CGMP violations can continue to sting long after the warning letter arrives. Caraco Pharmaceutical, for example, which continues its push toward regulatory compliance in an effort to resume ...

Caraco Pharmaceutical posts lower net income in second quarter

Crain's Detroit Business - 1 hour ago
By Jay Greene Caraco Pharmaceutical Laboratories (NYSE Amex: CPD) posted net income of $6.7 million for the second quarter 2010, or 16 cents per diluted share, down slightly from $8.4 million, or ...

Caraco Pharmaceutical posts lower net income in second quarter

/C O R R E C T I O N -- Caraco Pharmaceutical Laboratories, Ltd./

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010

FDA Cites KV, Caraco Actions in Enforcement Campaign

FDA news - 58 minutes ago
FDA Commissioner Margaret Hamburg's call for aggressive enforcement action has resulted in a campaign that ranges from actions against KV Pharmaceutical and Caraco Pharmaceutical Laboratories to ...

Caraco Pharmaceutical Laboratories, Ltd. (Caraco) is engaged in the business of developing, manufacturing, marketing and distributing generic and private-label pharmaceuticals to wholesalers, distributors, warehousing and non-warehousing chain drugstores and managed care providers, throughout the United States and Puerto Rico.